Moderna leads development of mRNA vaccines in infectious diseases: GlobalData
Moderna has Phase III pipeline candidates in four different indications (COVID-19, influenza, RSV, and cytomegalovirus) and is…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Spikevax
Moderna COVID-19 vaccine Spikevax sales to reduce amid strong competition: GlobalData
GlobalData expects Spikevax vaccine market share to decline from 30 per cent in 2022 to just 16 per cent by the end of 2028
Pfizer and BioNTech’s COVID-19 vaccine Comirnaty tops the list of best-selling drugs
Ends the nine-year reign of AbbVie’s Humira as the world’s best-selling pharma product
Australia provisionally approves Moderna’s COVID shot for children aged below five years
So far, the shot was provisionally approved in the country for individuals aged six years and older and as a booster dose for…
Moderna and Thermo Fisher partner to manufacture COVID vaccine
As a part of the 15-year expanded deal, Thermo Fisher would provide dedicated manufacturing capacity in the US for fill/finish…